Navigation Links
Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
Date:6/8/2012

THOUSAND OAKS, Calif., June 8, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced top-line results of the Phase 3 EVOLVE™ (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar®/Mimpara® (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis. The primary endpoint of the study was time to the composite event comprising all-cause mortality or first non-fatal cardiovascular event, including myocardial infarction, hospitalization for unstable angina, heart failure or peripheral vascular event. Although patients in the Sensipar/Mimpara arm experienced numerically fewer composite primary events, the results were not statistically significant, and the trial did not meet its primary endpoint in the intent-to-treat analysis.

"Amgen embarked on the EVOLVE trial to understand whether treating secondary HPT with Sensipar/Mimpara could positively impact the high rates of mortality and cardiovascular events among patients with CKD receiving dialysis," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen. "We thank the patients, caregivers and investigators for their participation and engagement in this landmark trial. EVOLVE will provide the nephrology community with important information."

The most frequently reported adverse events in the Sensipar/Mimpara arm of the trial were consistent with the known safety profile of this therapy and included nausea, vomiting and hypocalcemia.

Detailed efficacy and safety analyses from this landmark study are ongoing and will be submitted for presentation at a major medical meeting later this year.

Sensipar/Mimpara is an oral calcimimetic agent approved for the treatment of s
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
2. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
3. Amgen to Present at the Baird Growth Stock Conference
4. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
5. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
6. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
7. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
10. ERT Announces Clearance from German Federal Cartel Office
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... Diagnostic Device An ophthalmic diagnostic device ... or deficiency in the human visual pathway. Ophthalmic devices ... presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry eyes. ...
(Date:7/25/2014)...  Semler Scientific, Inc. (Nasdaq: SMLR ... that develops patented products that assist healthcare providers ... reported financial results for the second quarter and ... "The second quarter of 2014 continued to ... , M.D., chief executive officer of Semler.  "We ...
(Date:7/25/2014)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... report second quarter 2014 financial results before the NASDAQ ... That same day, Arena will host a conference call ... Pacific Time). The conference call may ... 914.495.8552 for international callers. Please specify to the operator ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3
... , CHICAGO , Jan. 14 ... Raman detection system for ultrasensitive immunoassays.  The system provides ... of low abundance markers.  These increases in performance could ... discovery, and clinical diagnostics development. , "We find the ...
... PARSIPPANY, N.J. , Jan. 14 As ... market, the company has announced the addition of three Vice ... these positions bring a deep knowledge of the spine and ... distribution networks in their respective areas.   , Randy ...
Cached Medicine Technology:Sword Diagnostics Announces Availability of Proprietary Detection Technology for Ultrasensitive Immunoassays. 2Custom Spine Announces the Expansion of its Sales Management Team 2
(Date:7/25/2014)... UT (PRWEB) July 25, 2014 ... surfaces for the recent Nike National Invitational Tournament ... current United States Junior National Tournament (USJN) ... 25. , The flooring for these prestigious national tournaments ... than 300,000 square feet of playing surface at McCormick ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Florida Hospital and ... two not-for-profit organizations for years to come and make a ... with a $2 million dollar check to provide the support ... investment will enable MOSI to transform the IMAX Dome Theatre ... MOSI has the only IMAX Dome Theatre in the state ...
(Date:7/25/2014)... 25, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Ibuprofen and Oxcarbazepine Tablets . ... lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by ... mislabeled packaging. Oxcarbazepine is used for the treatment of certain ... The reason for the recall is that Lot #142588, Expiration ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 A new study ... results of which are published today in Cancer , ... 55 and 74 who had an abnormal finding on a ... reduced quality of life than did those who were screened ... as a surprise to the researchers. “We expected that participants ...
(Date:7/25/2014)... July 25, 2014 This is ... state of the Galactooligosaccharides (GOS) industry in ... overview of the industry, including definitions, applications and ... domestic market analysis are provided with a focus ... the market. A comparison between the international and ...
Breaking Medicine News(10 mins):Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3
... Document Management,(Tricom), a company specializing in the electronic ... clientele, has announced the acquisition of,Pacific Data Centers, ... services to its clients so that they can ... 1967, PDC utilizes the latest technological advances and,state-of-the-art ...
... U.S. Senate to vote soon on legislation that ... Mississippi, WASHINGTON, July 9 Seniors across,Mississippi ... Medicare,Advantage program in legislation being considered in the ... million from the Medicare Advantage,program in Mississippi alone ...
... McCain Wrong on Veterans Health Care, WASHINGTON, ... Government Employees (AFGE) launched a nationwide radio ad,campaign ... health care. In addition to the radio ads, ... Affairs, launched a Web site, http://www.fundtheva.com, and ...
... Rochester Medical Center (URMC) will collaborate with the U.S. ... repository of data that will aid academic and industry ... addition to helping researchers understand many cardiac problems, the ... detect drugs that can have dangerous effects on the ...
... DALLAS, July 9 The Maltese healthcare system,will ... leaders from around the,world learn how the island ... model for the European Union to follow. Affiliated,Computer ... discuss the future,of healthcare and information technology while ...
... behavior threaten safety, quality, OAKBROOK TERRACE, Ill., July ... can test the limits of,civility in the workplace. A ... rude language and hostile behavior among health care,professionals goes ... safety and the overall quality of care., Intimidating ...
Cached Medicine News:Health News:Tricom Document Management Expands Onshore Services with Acquisition of Pacific Data Centers, Inc. 2Health News:Mississippi Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Union Representing VA Workers Launch Nationwide Radio Campaign, Web Site and Viral Videos for Full VA Funding 2Health News:URMC, FDA to collaborate on national data repository for heart research 2Health News:URMC, FDA to collaborate on national data repository for heart research 3Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 2Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 3Health News:Joint Commission Alert: Stop Bad Behavior Among Health Care Professionals 2Health News:Joint Commission Alert: Stop Bad Behavior Among Health Care Professionals 3
Ergotec Vetriretinal Instrument System. 2 mm pointed tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Angled shafts with 11 mm long tips. Jaws have longitudinal meshing serrations. Slide lock and serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish....
Serrated tips, straight platforms....
Medicine Products: